对患有严重抑郁症的门诊患者的临床行为,基于精神病医生的指导教育指南
Hirotaka Yamagata1,2, Kenta Ide1,3, Shinichiro Ochi4
1Department of Pathology of Mental Diseases National Center of Neurology and Psychiatry, National Institute of Mental Health Kodaira Tokyo Japan.
PCN reports : psychiatry and clinical neurosciences
|December 25, 2025
概括
精神病治疗指南传播和教育的有效性 (EGUIDE) 项目改善了主要抑郁症患者的严重性诊断. 然而,EGUIDE计划对精神病医生的处方行为产生了有限的影响.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 精神病治疗指南传播和教育的有效性 (EGUIDE) 项目以前加强了精神病医师对住院患者的指南的遵守.
- 对于患有重大抑郁症 (MDD) 的门诊患者,精神病医生的治疗行为仍未得到充分研究.
研究的目的:
- 评估EGUIDE计划对治疗诊断为MDD的门诊患者的精神病学家的临床实践的影响.
- 评估诊断的变化,药物处方模式和剂量等效性.
主要方法:
- 一项比较性研究涉及7个机构的255名患有MDD的门诊患者,并进行了至少6个月的跟踪.
- 分析处方类型,诊断率和药物剂量等价性 (抗抑郁药和抗焦虑药/催眠药) 在六个月的随访.
主要成果:
- 在EGUIDE项目中的精神病医生表明,MDD门诊患者的严重性诊断率显著更高.
- 在其他主要结局中没有发现显著差异,包括抗抑郁药单一治疗和抗焦虑/催眠药处方率.
- 在EGUIDE参与精神病学家治疗的患者中,观察到相当于Diazepam的抗焦虑药/催眠药剂量明显较低.
结论:
- 参与EGUIDE与大抑郁症外科患者的严重性诊断率的提高有关.
- 发现EGUIDE计划对MDD门诊患者的处方行为的影响有限.
相关概念视频
Treatment Strategies for Psychological Disorders
630
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
630
Depression: Overview
741
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
741
Depressive Disorders: MDD and Dysthymia
564
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
564
Diagnostic and Statistical Manual of Mental Disorders (DSM)
926
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
926
Acute Coronary Syndrome IV: Interprofessional Care
197
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
197
Antidepressant Drugs: MAOIs and Other Agents
765
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
765


